meixatch, I fear your right. They wanted to coupled this into a buyback of RD rights, trying to wait out things and get the RD rights back on the cheap, or obtain the funds do this. One or both issues fell apart, leaving them without a reason not to release the results. The why of how this drug worked in some ways and didn't in others is left to the observer, but releasing the results today or four months ago would have made no difference whatsoever... either in terms of share price change or mechanism of action.